Latest Shareholder Approval News

Finder Energy has successfully raised $6 million through a placement led by major shareholder Longreach Capital, aiming to accelerate its Kuda Tasi and Jahal offshore oil development towards a Final Investment Decision.

Resolution Minerals is set to begin its first exploration program at the Horse Heaven Project in Idaho, targeting gold, antimony, silver, and tungsten near a major US mining operation.

Austral Resources Australia Ltd has executed binding agreements to acquire the Rocklands Copper Mine, establishing a significant sulphide processing hub in North-West Queensland and advancing its regional consolidation strategy.

NT Minerals has agreed to sell its Redbank and Wollogorang copper projects to Golden Horse Minerals for $3 million in combined cash and equity, shifting its strategic focus to other critical mineral assets.

Keybridge Capital has obtained a $9.3 million bridge funding facility from Active Asset Management, supported by an ASX waiver allowing the deal without prior shareholder approval. The funding aims to address urgent liquidity and solvency challenges while trading remains suspended.

Yojee Limited has successfully raised $5.4 million through an oversubscribed placement, fueling development of its MOSAIC freight forwarding platform and expansion across the Asia Pacific region.

AuKing Mining has raised $1.177 million through a two-tranche share placement and signed a $5 million convertible loan facility with RiverFort Global Capital to support its Cloncurry Gold Project acquisition and development.

Pilot Energy has issued $600,000 in convertible notes under a previously approved $1.8 million facility with Discovery Investments, correcting a minor contractual reference without altering terms.

SRJ Technologies Group has voluntarily suspended its ASX trading as it prepares for a pivotal capital raising and shareholder meeting to secure its financial future.

MedAdvisor Limited has entered a binding agreement to sell its ANZ business division and intellectual property to Jonas Software for a headline price of $35 million plus an uncapped earn-out. The deal marks a strategic pivot as MedAdvisor focuses on its US operations.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

Vitasora Health Limited has raised $11 million in a well-supported placement, positioning the company to achieve cash flow breakeven in the second half of FY2026. The capital injection underscores strong investor confidence following key contract expansions and operational milestones.